Heterologous autoimmunity and prokaryotic immune defense

Abstract

Some prokaryotes possess CRISPR-Cas systems that provide adaptive immunity to viruses guided by DNA segments called spacers acquired from invading phage. However, the patchy incidence and limited memory breadth of CRISPR-Cas systems suggest that their fitness benefits are offset by costs. Here, we propose that cross-reactive CRISPR targeting can lead to heterologous autoimmunity, whereby foreign spacers guide self-targeting in a spacer-length dependent fashion. Balancing antiviral defense against autoimmunity predicts a scaling relation between spacer length and CRISPR repertoire size. We find evidence for this scaling through comparative analysis of sequenced prokaryotic genomes, and show that this association also holds at the level of CRISPR types. In contrast, the scaling is absent in strains with nonfunctional CRISPR loci. Finally, we demonstrate that stochastic spacer loss can explain variations around the scaling relation, even between strains of the same species. Our results suggest that heterologous autoimmunity is a selective factor shaping the evolution of CRISPR-Cas systems.

arXiv commentRevised manuscript with additional robustness checks. 11 pages with 4 figures + 10 pages supplement with 11 figures

References in corpus (10)

• How a well-adapted immune system is organized
• Diversity of immune strategies explained by adaptation to pathogen statistics
• How a well-adapting immune system remembers
• Optimal number of spacers in CRISPR arrays
• Early life imprints the hierarchy of T cell clone sizes
• The size of the immune repertoire of bacteria
• Mouse T cell repertoires as statistical ensembles: overall characterization and age dependence
• Dynamics of adaptive immunity against phage in bacterial populations
• Transitions in optimal adaptive strategies for populations in fluctuating environments
• Nonclassical phase diagram for virus bacterial co-evolution mediated by CRISPR